Last reviewed · How we verify

A Real-World Study of Toripalimab in Chinese Patients With Lung Cancer(THUNDER Study)

NCT05652712 UNKNOWN

Our project is going to clarify the efficacy and safety of Toripalimab in lung cancer in the real world, and to evaluate the incidence of adverse events (AEs) of special interest during Toripalimab immunotherapy.

Details

Lead sponsorQianfoshan Hospital
StatusUNKNOWN
Enrolment200
Start dateTue Jan 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionThu Jun 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Interventions

Countries

China